Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenetic mechanisms in peroxisomal disorders

H W Moser1

  • 1Neurogenetics Research Center, Kennedy Krieger Institute, Johns Hopkins University, Baltimore, MD 21205, USA.

Current Opinion in Neurology
|December 1, 1996
PubMed
Summary

Significant progress is being made in understanding peroxisomal disorders. Research is defining gene defects and exploring new therapies for X-linked adrenoleukodystrophy and peroxisome biogenesis disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts.

Journal of inherited metabolic disease·2009
Same author

Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy.

Neurology·2005
Same author

Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.

Neurology·2005
Same author

Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy.

Neurology·2003
Same author

Clinical and electrophysiological improvement of adrenomyeloneuropathy with steroid treatment.

Journal of neurology, neurosurgery, and psychiatry·2003
Same author

MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy.

Neurology·2003

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Peroxisomal disorders are a group of serious inherited metabolic diseases.
  • Two major classes exist: X-linked adrenoleukodystrophy (X-ALD) and peroxisome biogenesis disorders (PBDs).
  • Understanding their pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To review recent advances in the understanding of peroxisomal disorder pathogenesis.
  • To highlight progress in identifying genetic defects and exploring therapeutic strategies.
  • To categorize peroxisome biogenesis disorders through complementation analysis.

Main Methods:

  • Review of recent scientific literature on peroxisomal disorders.
  • Analysis of complementation data for peroxisome biogenesis disorder classification.

Related Experiment Videos

  • Identification and characterization of gene defects and mutations.

    • Main Results:

    • The specific gene defect in X-linked adrenoleukodystrophy has been identified.
    • Emerging therapies for X-linked adrenoleukodystrophy are showing promise.
    • Complementation analysis has enabled the categorization of peroxisome biogenesis disorders.
    • The molecular basis and specific mutations for PBDs are being defined.

    Conclusions:

    • Substantial advances have been made in elucidating the pathogenesis of major peroxisomal disorders.
    • Therapeutic strategies for X-linked adrenoleukodystrophy are advancing.
    • Ongoing research into peroxisome biogenesis disorders aims to define molecular underpinnings and explore novel therapies.